Real-World Evidence

Bagsværd, Denmark – September 18, 2025 – Novo Nordisk A/S announced landmark results from the REACH real-world study showing...

LONDON, Sept. 15, 2025 – AMO Pharma Limited, a privately held clinical-stage specialty biopharmaceutical company dedicated to rare genetic...